Greene, Jeremy Alan (Author)
*TRADEMARKS *HISTORY *GENERIC drugs *DRUGS *PHARMACEUTICAL industry *BRANDING (Marketing) *BRAND name products *MARKETING *INTELLECTUAL property UNITED States Author-Supplied Keywords: drug industry history of medicine intellectual property marketing pharmaceuticals trademarks NAICS/Industry Codes: 414510 Pharmaceuticals and pharmacy supplies merchant wholesalers 325410 Pharmaceutical and medicine manufacturing 424210 Drugs and Druggists' Sundries Merchant Wholesalers Abstract: This article narrates a late twentieth century controversy in American medicine over the clinical, public health, and financial value of `look-alike drugs' a set of generic pharmaceuticals that imitated their brand-name counterparts down to exact parameters of size, shape, and color. At stake in these conflicts was the emerging landscape of market exclusivity for formerly innovative pharmaceuticals once their patent rights expired. After the patent, which qualities of a brand-name drug could still be considered to be private property, and which became part of the public commons? This dispute invoked thorny epistemological questions about pharmaceuticals as therapeutic technologies. Was the active pharmaceutical ingredient (API) the only public, knowable part of a drug, while other parts -- binders, fillers, dyes, scores, and bevels -- could be kept as trade secrets? Did these other physical parts of a pill bear some clinical function as well? Could the color of a capsule affect its therapeutic effects? [ABSTRACT FROM PUBLISHER
...MoreArticle Gaudillière, Jean-Paul; Thoms, Ulrike (2013) Pharmaceutical Firms and the Construction of Drug Markets: From Branding to Scientific Marketing. History and Technology (pp. 105-115).
Article
Thoms, Ulrike;
(2013)
Standardizing Selling. Pharmaceutical Marketing, the Pharmaceutical Company and the Marketing Expert (1900--1980)
(/isis/citation/CBB001320755/)
Article
MacLeod, Roy;
(2007)
Preface
(/isis/citation/CBB000830070/)
Article
Yi, Doogab;
(2011)
Who Owns What? Private Ownership and the Public Interest in Recombinant DNA Technology in the 1970s
(/isis/citation/CBB001220006/)
Book
Hughes, Sally Smith;
(2011)
Genentech: The Beginnings of Biotech
(/isis/citation/CBB001221219/)
Book
Roberto Berveglieri;
(2020)
«Ingegnosi artificij»: Serenissima Repubblica di Venezia. Trecento anni di storia della scienza, della tecnica e dell’innovazione (1474-1788)
(/isis/citation/CBB667721442/)
Book
Joris Mercelis;
(2020)
Beyond Bakelite: Leo Baekeland and the Business of Science and Invention
(/isis/citation/CBB912550580/)
Chapter
Hayden, Cori;
(2011)
No Patent, No Generic: Pharmaceutical Access and the Politics of the Copy
(/isis/citation/CBB001221561/)
Book
Boldrin, Michele;
Levine, David K.;
(2008)
Against Intellectual Monopoly
(/isis/citation/CBB000954253/)
Book
Gaudilliére, Jean-Paul;
Thoms, Ulrike;
(2015)
The Development of Scientific Marketing in the Twentieth Century
(/isis/citation/CBB001551088/)
Article
Maffei, Nicolas P.;
(2013)
Selling Gleam: Making Steel Modern in Post-war America
(/isis/citation/CBB001201126/)
Article
Quirke, Viviane;
(2014)
Targeting the American Market for Medicines, ca. 1950s–1970s: ICI and Rhône-Poulenc Compared
(/isis/citation/CBB001202354/)
Article
Jean-Marie Yante;
(2020)
Le secteur pharmaceutique en Belgique au XXe siècle et à l’aube du XXIe siècle
(/isis/citation/CBB668228708/)
Book
Con Díaz Gerardo;
(2019)
Software Rights: How Patent Law Transformed Software Development in America
(/isis/citation/CBB992270814/)
Chapter
Samuelson, Pamela;
(2011)
The Strange Odyssey of Software Interfaces as Intellectual Property
(/isis/citation/CBB001221563/)
Article
Eda Kranakis;
(2019)
A Tale of Two Inventions: Monsanto, Biotechnology, and the Geography of Postmodern Science
(/isis/citation/CBB875215202/)
Article
Brad Sherman;
(2018)
Intangible Machines: Patent Protection for Software in the United States
(/isis/citation/CBB843796158/)
Article
Mercelis, Joris;
(2012)
Leo Baekeland's Transatlantic Struggle for Bakelite: Patenting Inside and Outside of America
(/isis/citation/CBB001250064/)
Article
Berman, Elizabeth Popp;
(2008)
Why Did Universities Start Patenting? Institution-Building and the Road to the Bayh-Dole Act
(/isis/citation/CBB000953521/)
Chapter
Kahn, Jonathan;
(2011)
Inventing Race as a Genetic Commodity in Biotechnology Patents
(/isis/citation/CBB001221562/)
Thesis
Loe, Meika E.;
(2002)
(De) constructing the Viagra phenomenon: Claims, markets, and the science of sex
(/isis/citation/CBB001562539/)
Be the first to comment!